Dataset Information

Proteomics Analysis of Trop2 Xenograft Prostate Tumors

ABSTRACT: Shotgun proteomic analysis of LNCaP-Trop2-OV tumor xenografts and LNCaP-RFP control tumors

INSTRUMENT(S): LTQ Orbitrap Elite

ORGANISM(S): Homo Sapiens (human) Mus Musculus (mouse)

TISSUE(S): Prostate Gland

DISEASE(S): Prostate Cancer

SUBMITTER: Sharon Pitteri

LAB HEAD: Sharon Pitteri

PROVIDER: PXD039272 | Pride | 2023-01-05

REPOSITORIES: Pride

ACCESS DATA

Publications

Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1.

Hsu En-Chi EC Rice Meghan A MA Bermudez Abel A Marques Fernando Jose Garcia FJG Aslan Merve M Liu Shiqin S Ghoochani Ali A Zhang Chiyuan Amy CA Chen Yun-Sheng YS Zlitni Aimen A Kumar Sahil S Nolley Rosalie R Habte Frezghi F Shen Michelle M Koul Kashyap K Peehl Donna M DM Zoubeidi Amina A Gambhir Sanjiv S SS Kunder Christian A CA Pitteri Sharon J SJ Brooks James D JD Stoyanova Tanya T

Proceedings of the National Academy of Sciences of the United States of America 20200113 4

Resistance to androgen deprivation therapy, or castration-resistant prostate cancer (CRPC), is often accompanied by metastasis and is currently the ultimate cause of prostate cancer-associated deaths in men. Recently, secondary hormonal therapies have led to an increase of neuroendocrine prostate cancer (NEPC), a highly aggressive variant of CRPC. Here, we identify that high levels of cell surface receptor Trop2 are predictive of recurrence of localized prostate cancer. Moreover, Trop2 is signif ...[more]

PMID: 31932422

Similar Datasets

Project description:Here we performed a transcriptomic study on complete symptom development process of CMV-infected Nicotiana tabacum using Solexa/Illumina's high-throughput digital gene expression (DGE) system. 12 DGE libraries (from six virus-infected samples and six corresponding mock-inoculated samples) were constructed, and the gene expression variations between the virus-infected sample and the mock-inoculated sample in each symptom stage were compared. Thousands of differentially expressed genes were obtained by the comparison, and KEGG pathway analysis of these genes suggested that many biological processes (such as phtosynthesis, pigment metabolism and plant-pathogen interaction) were related to the symptom development. The authenticity of the DGE data was further confirmed by analyzing real-time RT-PCR using several random-selected genes. We sequenced a cDNA library constructed from mixture of total RNA from six virus-infected samples and six mock-inoculated samples to get gene information for tobacco leaves in different symptom stages, including vein clearing, mosaic, severe chlorosis, partial recovery, total recovery and re-mosaic, and 95,916 Unigenes were obtained Tobacco leaves were inoculated by CMV-infected leaf homogenate and healthy leaf homogenate, respectivley. Six time points with different symptom stage were selected, and one virus-infect sample and one mock-inoculated sample were collected at each time. In order to average out variation of different plants, five leaves from five different plants were mixed to prepare every RNA sample. Twelve individual tag libraries of samples (six infected samples and six mock-inoculated samples) were constructed in parallel. For the gene expression analysis, the twelve samples were grouped into six groups, and each group contained a virus-infected sample and a mock-inoculated sample collected at the same time. In each group, the DGE data of virus-infected sample were compared to that of mock-inoculated sample to obtain the gene expression variations. Illumina sequencing of transcripts from virus-infected and mock-inoculated samples to get gene information for tobacco leaves in different symptom stages. In order to get more gene information, the systemically infected leaves and mock-inoculated leaves were harvested at six time points and five leaves from five different plants were collected at each time point. The RNA-Seq analysis provided gene information for mock-inoculated and virus-infected tobacco leaves in different symptom stages.

Dataset Information

Proteomics Analysis of Trop2 Xenograft Prostate Tumors

Publications

Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure